SARS-CoV-2 Envelope Protein Polyklonaler Antikörper
SARS-CoV-2 Envelope Protein Polyklonal Antikörper für ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
Virus und mehr (1)
Anwendung
IF, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 28904-1-AP
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in ELISA | Recombinant protein |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Enzyme-linked Immunosorbent Assay (ELISA) | ELISA : |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
IF | See 1 publications below |
Produktinformation
28904-1-AP bindet in IF, ELISA SARS-CoV-2 Envelope Protein und zeigt Reaktivität mit Virus
Getestete Reaktivität | Virus |
In Publikationen genannte Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Polyklonal |
Typ | Antikörper |
Immunogen | SARS-CoV-2 Envelope Protein fusion protein Ag30690 |
Vollständiger Name | COVID-19 E Protein |
GenBank-Zugangsnummer | NC_045512 |
Gene symbol | COVID-19 E Protein |
Gene ID (NCBI) | 43740570 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Antigen-Affinitätsreinigung |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Store at -20°C. Stable for one year after shipment. Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Envelope protein of coronaviruses is a structural protein existing in both monomeric and homopentameric form. It is a minor component of the virus membrane though it is deemed to be important for many stages including virus infection, replication, dissemination and immune response stimulation. Sequence comparison has shown that this protein is identical to the counterparts of specific Bat and Pangolin coronavirus isolates, even though the Sars-CoV-2 sequence seems to possess specific modifications and characteristics with respect to other Sars CoVs(PMID:32596311). The SARS-CoV-2 envelope protein provide a strategy to assess cross-protection against COVID-19 (PMID: 32446902).
Publikationen
Species | Application | Title |
---|---|---|
Front Cell Neurosci The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model |